{{org_field_logo}}
{{org_field_name}}
Registration Number: {{org_field_registration_no}}
Asthma Management Policy
1. Purpose
The purpose of this Asthma Management Policy is to ensure the safety, wellbeing, and appropriate care of all individuals within {{org_field_name}} who have asthma. This policy outlines the measures taken to prevent asthma attacks, manage symptoms effectively, and respond to emergencies in a timely and efficient manner. By implementing this policy, {{org_field_name}} commits to providing a safe, inclusive, and informed environment for service users and employees affected by asthma.
2. Scope
This policy applies to all service users, employees, and stakeholders within {{org_field_name}}. It covers prevention strategies, medication management, emergency response, environmental control, training, and education. Our objective is to create an asthma-friendly environment that reduces risks and ensures everyone receives appropriate support.
3. Legal and Regulatory Framework
This policy will be implemented in accordance with the following current legislation, regulations and national guidance:
- Health and Social Care Act 2008 and Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, including:
- Regulation 9 – Person-centred care.
- Regulation 10 – Dignity and respect.
- Regulation 11 – Need for consent.
- Regulation 12 – Safe care and treatment.
- Regulation 17 – Good governance.
- Regulation 18 – Staffing.
- Regulation 20 – Duty of Candour.
- Human Medicines Regulations 2012, as amended – governing the lawful supply and use of human medicines, including prescription-only asthma medicines.
- Mental Capacity Act 2005 and associated Code of Practice – where a person may lack capacity to make a particular decision relating to their asthma treatment or medicines support.
- Equality Act 2010 – protecting disabled people from unlawful discrimination and requiring reasonable adjustments where appropriate. Asthma may constitute a disability where the statutory definition is met, including where the condition has a substantial and long-term adverse effect on the person’s ability to carry out normal day-to-day activities.
- Care Act 2014 – including person-centred assessment, wellbeing and prevention principles relevant to adults receiving care and support.
- Health and Safety at Work etc. Act 1974 and applicable health and safety regulations – including responsibilities towards employees and others who may be affected by work activities.
- NICE/BTS/SIGN Guideline NG245 – Asthma: diagnosis, monitoring and chronic asthma management, published in November 2024 and subsequently updated.
- NICE Guideline NG67 – Managing medicines for adults receiving social care in the community, where {{org_field_name}} provides medicines support.
- Current NHS guidance on recognising and responding to an asthma attack.
- Current CQC guidance on medicines management, medicines records, staff training and competency in adult social care.
{{org_field_name}} will ensure that asthma-related support is person-centred and consistent with the individual’s current prescription, healthcare-professional instructions, personalised asthma action plan and agreed care plan.
Care staff must work within the limits of their role and competence and must not independently diagnose asthma, prescribe treatment or alter prescribed asthma medication.
4. Identifying and Managing Asthma
Upon enrolment or employment, all individuals will be encouraged to disclose any history of asthma. For service users diagnosed with asthma, a personalised Asthma Care Plan (ACP) will be created in collaboration with healthcare professionals, families, and carers. Employees with asthma will also have access to support mechanisms to ensure their condition is effectively managed while at work.
The ACP will outline:
- Specific triggers and early warning signs of an asthma attack.
- Prescribed medication, including dosage and frequency of use.
- Instructions on how and when to use reliever and preventer inhalers.
- Contact details for emergency services, healthcare providers, and next of kin.
- A structured response plan in case of an asthma exacerbation.
Staff will be trained to recognise the symptoms of an impending asthma attack and will be required to follow the ACP to ensure a swift and effective response.
5. Preventative Measures
To proactively minimise asthma-related risks, {{org_field_name}} will:
- Conduct regular risk assessments to identify and eliminate asthma triggers such as dust, strong odours, pet hair, pollen, and smoke.
- Maintain high air quality through ventilation, regular cleaning, and the use of air purifiers where necessary.
- Implement no-smoking policies in all premises, ensuring both indoor and outdoor spaces are free from tobacco smoke and vapours.
- Educate service users and employees on the importance of recognising personal asthma triggers and strategies to manage exposure.
- Ensure that individuals with asthma are provided with safe spaces in case of exposure to a trigger, offering a quick and calm retreat where they can manage symptoms effectively.
These preventive measures are designed to create an asthma-friendly environment that enables individuals to participate in activities safely and comfortably.
6. Medication Management
{{org_field_name}} will support people with asthma medicines only where the required level of medicines support has been assessed, agreed and documented in the person’s care plan.
Where staff provide support with an inhaler, nebulised medicine or other asthma treatment, the care plan must identify:
- The medicine and device prescribed.
- The purpose of the medicine.
- Whether it is a regular, preventative or when-required medicine.
- The prescribed dose and frequency.
- How and when the medicine should be used.
- Any minimum interval or maximum dose applying to a when-required medicine.
- Whether a spacer or other device is required.
- The level of support the person needs.
- Relevant monitoring requirements.
- When staff must seek healthcare-professional advice.
- The person’s current asthma action plan where available.
6.1. Person’s Own Asthma Medicines
Asthma inhalers and other prescribed asthma medicines belong to the individual for whom they were prescribed.
They must not be:
- Shared between service users.
- Used by another person.
- Transferred from one person’s medicines supply to another.
- Used as general organisational emergency stock unless there is a specific lawful basis permitting this.
{{org_field_name}} will not routinely hold communal or generic spare salbutamol inhalers or emergency asthma medicines for service users.
The statutory arrangements allowing certain emergency salbutamol inhalers to be obtained without an individual prescription for use in emergencies relate to specified settings such as schools and must not be assumed to apply to a domiciliary care provider.
Service users should be supported, where necessary, to ensure that their own prescribed reliever medication is available and accessible in accordance with their care plan.
6.2. Storage and Accessibility
Asthma medicines will be stored according to:
- The person’s wishes and abilities.
- Their medicines risk assessment.
- Manufacturer and dispensing instructions.
- The need for the medicine to remain accessible when required.
A reliever inhaler must not be stored in a way that creates an avoidable delay in access during an asthma attack.
Where a person self-administers their inhaler, the care plan should support them to retain appropriate access and control wherever possible.
6.3. Administration and Recording
Where staff administer or provide medicines support, they must:
- Follow the current prescription and care plan.
- Confirm the correct person and medicine.
- Follow the prescribed dose, route and timing.
- Respect the person’s right to decline.
- Use the correct inhaler, spacer or other prescribed device.
- Record medicines support in accordance with {{org_field_name}}’s medicines procedures.
- Record when-required medication where staff have provided the support.
- Record and report any refusal, error, adverse reaction or concern.
Care workers must not independently alter a person’s prescribed asthma treatment.
Changes to inhalers, doses or treatment regimes must come from an appropriate prescriber or healthcare professional.
6.4. Inhalers and Nebulisers
Staff who assist with or administer inhaled or nebulised medicines must have training appropriate to the specific task and must be assessed as competent before carrying it out independently.
Competency should include, where relevant:
- Correct use of the person’s prescribed inhaler device.
- Use of spacers.
- Recognition of common technique errors.
- Cleaning and care of relevant equipment.
- Nebuliser use where this forms part of the person’s agreed care.
- Recognition of deterioration and escalation requirements.
- Appropriate medicines recording.
Nebulised medicines must only be administered in accordance with the person’s prescription and current care plan.
7. Emergency Response Protocol
Every person with asthma who requires staff support should have clear individual emergency instructions available to staff, preferably based on their current personalised asthma action plan.
The person’s own action plan takes priority where it contains specific emergency instructions agreed by their healthcare professional.
Where an asthma attack is suspected:
- Help the person to sit upright and remain as calm as possible.
- Do not encourage the person to lie flat.
- Help them access their prescribed reliever inhaler immediately.
- Follow their personalised asthma action plan where available.
- Monitor the person’s condition continuously.
7.1. Blue Reliever Inhaler
Where the person’s prescribed emergency reliever is a conventional blue reliever inhaler and their asthma action plan does not provide different instructions:
- Support them to take 1 puff every 30 to 60 seconds.
- Shake the inhaler between puffs where appropriate to the device.
- Use a spacer where available and appropriate.
- Continue until symptoms improve, up to a maximum of 10 puffs.
7.2. AIR or MART Reliever Inhaler
Some people now use an AIR or MART inhaler containing an inhaled corticosteroid and formoterol for symptom relief rather than a conventional blue reliever.
Where this is the person’s prescribed reliever and their asthma action plan does not give different instructions:
- Support them to take 1 puff every 1 to 3 minutes.
- Continue until they feel better, up to the maximum emergency dose specified in current NHS guidance, normally 6 puffs, unless their personalised asthma action plan states otherwise.
Staff must not assume that every person with asthma uses a blue salbutamol inhaler.
7.3. Call 999
Call 999 immediately where:
- The person becomes worse at any point.
- They do not improve after taking the maximum emergency dose of their prescribed reliever.
- They do not have access to their reliever inhaler during an asthma attack.
- They lose consciousness.
- They become severely exhausted or unresponsive.
- They have severe difficulty breathing or speaking.
- Staff are otherwise seriously concerned about their condition.
Do not wait for five minutes before calling 999 where one of these criteria is already present.
7.4. While Waiting for an Ambulance
While awaiting emergency assistance:
- Stay with the person.
- Continue to reassure them.
- Keep them sitting upright where possible.
- Follow instructions provided by the emergency call handler.
- Monitor breathing and level of consciousness.
- Be prepared to provide basic life support if required and if trained to do so.
If the ambulance has not arrived after 10 minutes and the person’s symptoms have not improved, the reliever inhaler may be used again up to the same maximum emergency dose in accordance with current NHS advice, the person’s asthma action plan and emergency-service instructions.
7.5. Following an Asthma Attack
After an asthma attack:
- Complete an incident record.
- Record the treatment and support provided.
- Record whether emergency services were contacted.
- Inform the Registered Manager or appropriate manager.
- Ensure relevant healthcare professionals are informed where appropriate.
- Review the person’s domiciliary care plan and risk assessment.
- Ensure the personalised asthma action plan is reviewed by an appropriate healthcare professional where required.
Staff must not independently alter the person’s asthma treatment following an attack.
8. Staff Training and Education
To ensure effective asthma management, all staff will undergo mandatory asthma training covering:
- Recognising symptoms of an asthma attack and early intervention strategies.
- Correct use of inhalers and other prescribed asthma medications.
- Emergency response procedures, including first aid and when to escalate care.
- Creating asthma-friendly environments by minimising exposure to triggers.
- Providing emotional and psychological support to individuals managing asthma.
Training will be delivered through workshops, e-learning modules, and practical demonstrations, ensuring that all employees are equipped to respond effectively to asthma-related situations.
9. Environmental Control and Risk Assessment
Asthma risks will be assessed in a person-centred way.
Because {{org_field_name}} provides care in people’s own homes, staff must distinguish between:
- Hazards that the organisation controls.
- Hazards within a person’s private home that can only be addressed with the person’s agreement or through other lawful arrangements.
Risk assessments should consider known individual triggers where relevant, including:
- Tobacco smoke and vaping.
- Dust.
- Mould and damp.
- Pollen.
- Animal allergens.
- Air pollution.
- Strong fragrances.
- Aerosols or cleaning chemicals.
- Cold air.
- Occupational or activity-related exposures.
- Other triggers identified in the person’s personalised asthma action plan.
Where a potential trigger is identified in a service user’s home, staff should:
- Discuss the concern with the person.
- Respect the person’s rights and choices.
- Explain relevant health risks where appropriate.
- Record significant risks.
- Agree proportionate control measures through the care plan.
- Escalate concerns where an environmental hazard creates a serious risk that cannot be adequately managed.
{{org_field_name}} must not impose blanket restrictions on a person’s private home merely because the organisation considers them desirable.
Organisational Premises and Work Activities
For premises, equipment and work activities controlled by {{org_field_name}}, appropriate measures will be taken to reduce avoidable respiratory risks, including:
- Appropriate ventilation.
- Safe selection and use of cleaning products.
- Control of smoke, fumes, aerosols and other irritants.
- Appropriate workplace risk assessment.
- Reasonable adjustments for employees where required.
Generic “emergency asthma stations” containing prescription-only inhalers will not be maintained unless there is a specific lawful basis permitting the organisation to obtain and hold those medicines.
The priority in domiciliary care is to ensure that each service user’s own prescribed reliever medicine is accessible when required and that staff know how to respond in accordance with the person’s individual asthma action plan.
10. Supporting Service Users and Employees with Asthma
{{org_field_name}} is committed to ensuring that individuals with asthma can live and work without unnecessary barriers. Support includes:
- Flexible work or living arrangements to accommodate those with severe asthma.
- Providing adequate breaks to those who may need time to use their inhalers or rest after an attack.
- Ensuring an open-door policy for discussing asthma-related concerns.
- Regular reviews of individual asthma management plans to ensure that the best possible care is provided.
11. Monitoring and Review
This policy will be reviewed at least annually, or sooner where necessary, to ensure that asthma-related care remains safe, person-centred and consistent with current legislation, CQC requirements and national clinical guidance.
An earlier review will take place where:
- NICE/BTS/SIGN asthma guidance is materially revised.
- NHS emergency asthma-attack guidance changes.
- Human medicines legislation materially changes.
- CQC medicines guidance materially changes.
- CQC requirements concerning safe care, medicines management, staffing or governance materially change.
- A serious asthma-related incident occurs.
- An asthma-related hospital admission or emergency response identifies weaknesses in the person’s care arrangements.
- Repeated medication or inhaler-support errors occur.
- Audits identify shortcomings in staff knowledge or competency.
- New inhaler devices or treatment approaches materially affect staff support arrangements.
The Registered Manager will ensure that monitoring includes, where relevant:
- Asthma-related care plans.
- Personalised asthma action plans available to staff.
- Individual asthma triggers.
- Accessibility of prescribed reliever medicines.
- PRN or when-required inhaler protocols.
- Medicines administration records.
- Inhaler and nebuliser competency.
- Asthma-related incidents.
- Emergency-service involvement.
- Hospital admissions known to the service.
- Environmental risk concerns.
- Staff training.
- Reasonable adjustments.
- Feedback from service users.
- Relevant CQC findings.
Following an asthma attack or significant deterioration, the organisation will review whether:
- The person’s care plan remains accurate.
- Their current personalised asthma action plan is available to staff.
- Staff understand which reliever inhaler the person uses.
- Emergency instructions remain current.
- Medicines support arrangements remain appropriate.
- Additional healthcare-professional input is required.
Where weaknesses are identified, {{org_field_name}} will:
- Update care plans and risk assessments.
- Seek appropriate healthcare-professional advice.
- Review medicines-support arrangements.
- Review staff competency.
- Provide additional training or supervision.
- Correct environmental or organisational risks within the provider’s control.
- Implement corrective and preventative action.
Material changes to this policy will be documented, approved and communicated to relevant staff.
Learning from asthma attacks, medicines incidents, complaints, audits and feedback will be used to continuously improve the safety and quality of asthma support.
Responsible Person: {{org_field_registered_manager_first_name}} {{org_field_registered_manager_last_name}}
Reviewed on: {{last_update_date}}
Next Review Date: {{next_review_date}}
Copyright © {{current_year}} – {{org_field_name}}. All rights reserved.